An open-label multiyear study of sargramostim-treated Parkinson’s disease patients examining drug safety, tolerability, and immune biomarkers from limited case numbersarticle Published on 2023-05-222024-09-05 Journal: Translational Neurodegeneration [Category] update2024, [키워드] Granulocyte–macrophage colony-stimulating factor neuroprotection Parkinson’s disease regulatory T cells Sargramostim therapy Unified Parkinson’s Disease Rating Scale [DOI] 10.1186/s40035-023-00361-1 PMC 바로가기 [Article Type] article
Efficacy and safety of granulocyte-macrophage colony-stimulating factor (GM-CSF) antibodies in COVID-19 patients: a meta-analysisReview Published on 2023-02-012024-09-02 Journal: InflammoPharmacology [Category] 대상포진, [키워드] antibody COVID-19 Granulocyte–macrophage colony-stimulating factor Meta-analysis [DOI] 10.1007/s10787-022-01105-9 PMC 바로가기 [Article Type] Review